Literature DB >> 28502825

Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantation.

Markus G Seidel1, Katrin Böhm2, Figen Dogu3, Austen Worth4, Adrian Thrasher4, Benoit Florkin5, Aydan İkincioğulları3, Anke Peters6, Shahrzad Bakhtiar7, Marie Meeths8, Polina Stepensky9, Isabelle Meyts10, Svetlana O Sharapova11, Laura Gámez-Díaz12, Lennart Hammarström13, Stephan Ehl14, Bodo Grimbacher12, Andrew R Gennery15.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28502825     DOI: 10.1016/j.jaci.2017.04.023

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  18 in total

1.  Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.

Authors:  Ayca Kiykim; Ismail Ogulur; Esra Dursun; Louis Marie Charbonnier; Ercan Nain; Sukru Cekic; Dilek Dogruel; Neslihan Edeer Karaca; Mujde Tuba Cogurlu; Ozlem Arman Bilir; Murat Cansever; Hasan Kapakli; Dilek Baser; Nurhan Kasap; Seyhan Kutlug; Derya Ufuk Altintas; Ahmad Al-Shaibi; Nourhen Agrebi; Manolya Kara; Ayla Guven; Ayper Somer; Cigdem Aydogmus; Nuray Aktay Ayaz; Ayse Metin; Metin Aydogan; Aysen Uncuoglu; Turkan Patiroglu; Alisan Yildiran; Sukru Nail Guner; Sevgi Keles; Ismail Reisli; Guzide Aksu; Necil Kutukculer; Sara S Kilic; Mustafa Yilmaz; Elif Karakoc-Aydiner; Bernice Lo; Ahmet Ozen; Talal A Chatila; Safa Baris
Journal:  J Allergy Clin Immunol Pract       Date:  2019-06-22

Review 2.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

Review 3.  Allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.

Authors:  Emma C Morris
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

4.  Novel LRBA Mutation and Possible Germinal Mosaicism in a Slavic Family.

Authors:  Svetlana O Sharapova; Emma Haapaniemi; Inga S Sakovich; Jessica Rojas; Laura Gámez-Díaz; Yuliya E Mareika; Irina E Guryanova; Alexandr A Migas; Taisiya M Mikhaleuskaya; Bodo Grimbacher; Olga V Aleinikova
Journal:  J Clin Immunol       Date:  2018-05-26       Impact factor: 8.317

Review 5.  Primary B-cell immunodeficiencies.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Hum Immunol       Date:  2018-10-22       Impact factor: 2.850

6.  Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patients.

Authors:  Oded Shamriz; Bella Shadur; Adeeb NaserEddin; Irina Zaidman; Natalia Simanovsky; Orly Elpeleg; Eitan Kerem; Joel Reiter; Polina Stepensky
Journal:  Eur J Pediatr       Date:  2018-05-18       Impact factor: 3.183

Review 7.  Bacille Calmette-Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010-2017.

Authors:  Cristiane de Jesus Nunes-Santos; Sergio D Rosenzweig
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

8.  Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome.

Authors:  Sanem Eren Akarcan; Neslihan Edeer Karaca; Guzide Aksu; Ayca Aykut; Deniz Yilmaz Karapinar; Funda Cetin; Yesim Aydinok; Elif Azarsiz; Eleonora Gambineri; Ozgur Cogulu; Ezgi Ulusoy Severcan; Hudaver Alper; Necil Kutukculer
Journal:  JMM Case Rep       Date:  2018-10-15

Review 9.  Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency.

Authors:  Andrew R Gennery; Arjan Lankester
Journal:  Front Pediatr       Date:  2019-09-24       Impact factor: 3.418

10.  Novel compound heterozygous stop-gain mutations of LRBA in a Vietnamese patient with Common Variable Immune Deficiency.

Authors:  Anh N L Phan; Thuy T T Pham; Nghia Huynh; Tuan M Nguyen; Cuc T T Cao; Duong T Nguyen; Duc T Le; Chi-Bao Bui
Journal:  Mol Genet Genomic Med       Date:  2020-03-10       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.